Anebulo Pharmaceuticals (ANEB) PT Lowered to $8 at Benchmark
Tweet
Share
E-mailGet Alerts ANEB Hot Sheet
Price: $0.36 --0%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
Benchmark analyst Robert Wasserman lowered the price target on Anebulo Pharmaceuticals (NASDAQ: ANEB) to $8.00 (from $10.00) while maintaining a Speculative Buy rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
- South32 Ltd (S32:LN) (SOUHY) PT Raised to GBP3.20 at Citi
- T. Rowe Price (TROW) PT Raised to $110 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
